RSS

NIO NIO Inc.

Mod: g&l
Last Post: 05/28/25
Followers: 1
Posts Today: 0
Views Today: 5840

NIO Stock Quote & Tools

$5.5900 ▲ +0.0000 (+0.00%) As of May 20, 4:00 PM EDT
Last5.5900
$ Chg0.0000
Open—
High—
Beta0.9748
Year High8.020
Market Cap14.01B
P/B Ratio23.49
EPS-0.98
Avg Vol (30d)33.57M
Volume13.62M
% Chg+0.00%
Prev Close5.5900
Low—
VWAP5.90936
Year Low3.340
Total Shares2.51B
Shares Out2.36B
Float2.14B
ExchangeNYSE
Consumer Discretionary Vehicles

NIO Stock Message Board Discussion

Top 10 Most Recent News Articles

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 108

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 119

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 174

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 90

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 234

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 113

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading

Top 5 Most Recently Viewed Articles

Denali's Remarkable Impact: 14 Billion Pounds of Recycling Triumph

Updated Category News Views 99

Denali's Massive Recycling Achievement Denali, a leader in the organic recycling sector, has made headlines with its extraordinary accomplishment of recycling 14 billion pounds of organic materials and byproducts in just one year. This remarkable feat, outlined in its latest annual sustainability report, showcases Denali's dedication to advancing sustainability and...

Continue Reading
Prologis Set to Reveal Fourth Quarter Insights in Early 2026

Updated Category News Views 221

Prologis to Release Fourth Quarter Results Prologis, Inc. (NYSE: PLD), a major player in logistics real estate, is preparing to announce its fourth quarter results. This essential event will take place in early January 2026, providing a valuable opportunity for investors and stakeholders to gain insights into the company's performance and future direction. Details of the...

Continue Reading
Joel Hodgson Reveals Insights on Creativity in Exclusive Podcast

Updated Category News Views 163

Exclusive Insights from Joel Hodgson In the latest episode of Edge of Cinema's podcast Stories From the Top, the renowned creator of Mystery Science Theater 3000 (MST3K), Joel Hodgson, shares his remarkable journey as a comedian and innovator. Known for his passion for creativity, this episode takes listeners on a fascinating adventure through Hodgson's early interests in...

Continue Reading
Mo3 Estate Triumphs Over Sound Engineer in Copyright Case

Updated Category News Views 513

Mo3 Estate's Landmark Copyright Lawsuit Victory The Estate of Melvin Noble, Jr., known worldwide as the celebrated artist Mo3, has achieved a major win against former sound engineer Ray Gene Bollin, Jr. This case, which revolved around crucial allegations of copyright infringement and other claims, underscores a pivotal moment not just for Mo3, but for artists everywhere....

Continue Reading
Monetary Gold: A Quarter-Century of Trust in Precious Metals

Updated Category News Views 147

Monetary Gold: A Foundation of Trust For over 25 years, Monetary Gold has been a beacon of trust and stability in the precious metals industry. The firm's commitment to clients and resilience through various economic challenges highlights its dedication to providing peace of mind for investors. Celebrating a Legacy of Integrity Since its establishment, Monetary Gold has...

Continue Reading